Inventor · disambiguated record
Richard Klar
Also filed as: KLAR RICHARD
2 granted patents·8 pending applications·0 citations·filing 2017–2021
25Inventor score
Top patents by PatentIndex Score
10 records- 0151US2024076673A1Oligonucleotides reducing the amount of CD73 mRNA and CD73 protein expressionSECARNA PHARMACEUTICALS GMBH & CO KG·Filed 2021·Application pending·0 cites
- 0248US11781136B2Oligonucleotide inhibiting the expression of ChopSECARNA PHARMACEUTICALS GMBH & CO KG·Filed 2018·Granted Oct 10, 2023·0 cites·12 claims
- 0348US2023183708A1PD-1-specific antisense oligonucleotide and its use in therapySECARNA PHARMACEUTICALS GMBH & CO KG·Filed 2021·Application pending·0 cites
- 0447US2022372482A1Modified antisense oligonucleotide for inhibition of FoxP3 expressionSECARNA PHARMACEUTICALS GMBH & CO KG·Filed 2020·Application pending·0 cites
- 0546US2022372479A1Oligonucleotide based ex vivo cell therapySECARNA PHARMACEUTICALS GMBH & CO KG·Filed 2020·Application pending·0 cites
- 0646US2024067973A1Oligonucleotide for reducing the expression of angiotensin-converting enzyme 2 (ACE2) and its use for treating viral infectionTHE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV·Filed 2021·Application pending·0 cites
- 0742US11666595B2Antisense oligonucleotides for inhibition of PD-L1 expression and treating cancerSECARNA PHARMACEUTICALS GMBH & CO KG·Filed 2017·Granted Jun 6, 2023·0 cites·5 claims
- 0841US2023067620A1Inhibitor of metadherin expressionSECARNA PHARMACEUTICALS GMBH & CO KG·Filed 2020·Application pending·0 cites
- 0939US2022220485A1PD-L1 antisense oligonucleotides for use in tumor treatmentSECARNA PHARMACEUTICALS GMBH & CO KG·Filed 2020·Application pending·0 cites
- 1034US2020163988A1Immunosuppression-Reverting Oligonucleotides Inhibiting the Expression of IDOSECARNA PHARMACEUTICALS GMBH & CO KG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Klar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →